MAWAG
CABA icon

Mid-American Wealth Advisory Group’s Cabaletta Bio CABA Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91
Closed -$138 – 83
2025
Q2 		$138 Buy
+91
New +$142 ﹤0.01% 330

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Mid-American Wealth Advisory Group's CABA Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 91 shares — an estimated $138 sold.

Mid-American Wealth Advisory Group first reported a position in CABA in Q2 2025 and held it in 1 quarter. The position peaked at $138 in Q2 2025. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • Mid-American Wealth Advisory Group reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • Mid-American Wealth Advisory Group sold 91 Cabaletta Bio shares in Q3 2025, an estimated $138.
  • Mid-American Wealth Advisory Group first reported a position in Cabaletta Bio in Q2 2025 and held it in 1 quarter.
  • Mid-American Wealth Advisory Group's Cabaletta Bio position peaked at $138 in Q2 2025.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.